Skip to Main Content

RFU research implicates hydrogen sulfide in obesity-related inflammation

A new study by a team of RFU researchers identifies the gaseous signaling molecule hydrogen sulfide as an important regulator of the chronic, low-level inflammation caused by obesity that is associated with insulin resistance and the likelihood of developing type 2 diabetes.

Featured as the Dec. 15 cover of the journal Science Signaling, the paper is co-authored by investigators from the departments of Physiology and Biophysics and Microbiology and Immunology, including lead author Gopal V. Velmurugan, PhD '13, and Huiya Huang, PhD '15.

Posted December 15, 2015

More News Stories

Chicago Medical School alum, physician and healthcare entrepreneur encourages…
Saros Therapeutics, part of Rosalind Franklin University’s (RFU) Helix…
Rosalind Franklin University of Medicine and Science (RFU) and Xcellerant…